NCT04868708 2025-03-04A Study of AK104( an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical CancerAkesoPhase 2 Completed50 enrolled
NCT05490719 2024-05-21A Phase II Study of CRT Combined With QL1706 in ESCC PatientsTianjin Medical University Cancer Institute and HospitalPhase 2 Recruiting39 enrolled